The PE Ratio as of November 2025 (TTM) for Applied Genetic Technologies Corporation (AGTC) is -0.27

According to Applied Genetic Technologies Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.27. This represents a change of -50.21% compared to the average of -0.54 of the last 4 quarters.

Applied Genetic Technologies Corporation (AGTC) Historical PE Ratio (quarterly & annually)

How has AGTC PE Ratio performed in the past?

The mean historical PE Ratio of Applied Genetic Technologies Corporation over the last ten years is -2.54. The current -0.27 PE Ratio has changed 963.40% with respect to the historical average. Over the past ten years (40 quarters), AGTC's PE Ratio was at its highest in in the March 2016 quarter at 32.01. The PE Ratio was at its lowest in in the December 2013 quarter at -67.25.

Applied Genetic Technologies Corporation (AGTC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Applied Genetic Technologies Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Applied Genetic Technologies Corporation (AGTC) Average PE Ratio

How has AGTC PE Ratio performed in the past?

The current PE Ratio of Applied Genetic Technologies Corporation (AGTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Applied Genetic Technologies Corporation (AGTC) PE Ratio vs. Peers

How is AGTC’s PE Ratio compared to its peers?

Applied Genetic Technologies Corporation’s PE Ratio is greater than Marinus Pharmaceuticals, Inc. (-0.52), greater than Harpoon Therapeutics, Inc. (-1.14), greater than Freeline Therapeutics Holdings plc (-0.29), greater than Metacrine, Inc. (-0.40), greater than Serina Therapeutics, Inc. (-2.76), greater than Allakos Inc. (-0.42), greater than Kineta, Inc. (-0.96), greater than Angion Biomedica Corp. (-0.27), greater than Axcella Health Inc. (-3.61), greater than Elevation Oncology, Inc. (-0.45),

Build a custom stock screener for Applied Genetic Technologies Corporation (AGTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Genetic Technologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Genetic Technologies Corporation (AGTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Genetic Technologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.